Dr. Escobar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
505 Parnassus Avenue
San Francisco, CA 94143
Summary
- Dr. Daniel Escobar is an infectious disease specialist in San Francisco, CA and is affiliated with UCSF Medical Center. He received his medical degree from Lewis Katz School of Medicine at Temple University and has been in practice 6 years. In addition to his clinical infectious diseases work, he is the current associate medical director of hospital epidemiology and infection prevention at UCSF.
Education & Training
- University of Pennsylvania Health SystemFellowship, Infectious Disease, 2019 - 2021
- University of MarylandChief Residency, Internal Medicine, 2017 - 2018
- University of MarylandResidency, Internal Medicine, 2014 - 2017
- Lewis Katz School of Medicine at Temple UniversityClass of 2014, MD
- The Johns Hopkins UniversityMS, Cell and Molecular Biology , 2008 - 2009
- The Johns Hopkins UniversityBA, Biology & Romance Languages and Literature , 2004 - 2008
Certifications & Licensure
- CA State Medical License 2021 - 2025
- PA State Medical License 2019 - 2021
- HI State Medical License 2018 - 2020
- MD State Medical License 2017 - 2018
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Medical Honor Society
- Outstanding Clinical Fellow in Infectious Diseases Award Hospital of the University of Pennsylvania, 2021
Publications & Presentations
PubMed
- 7 citationsInfectious Diseases Consultation Associated With Reduced Mortality in Gram-Negative Bacteremia.Stephanie Shulder, Pranita D Tamma, Suiyini Fiawoo, Kathryn Dzintars, Daniel Escobar
Clinical Infectious Diseases. 2023-11-11 - 2 citationsSevere recurrence of reactive infectious mucocutaneous eruption with extensive ocular involvement in an adult due to SARS-CoV-2.David Wu, Ernest Y Lee, Jacob Lifton, Shannon W Zullo, Kira Seiger
JAAD Case Reports. 2023-06-01 - 13 citationsSecondary Cases of Delta-Variant COVID-19 Among Vaccinated Healthcare Workers with Breakthrough Infections is Rare.Sarah Waldman, Tara Buehring, Daniel J Escobar, Shruti K. Gohil, Ralph Gonzales
Clinical Infectious Diseases. 2021-10-25
Journal Articles
- Severe Recurrence of Reactive Infectious Mucocutaneous Eruption with Extensive Ocular Involvement in an Adult due to SARS-CoV-2David Wu, PhD,a,b Ernest Y. Lee, MD, PhD,c Jacob Lifton, MD,d Shannon W. Zullo, MD,c Kira Seiger, MD, MBA,c Rangarajan Nadadur, MD, PhD,e Lindy P. Fox, MD,c Daniel J. ..., JAAD Case Rep, 2/16/2023
- Secondary Cases of Delta-Variant COVID-19 Among Vaccinated Healthcare Workers with Breakthrough Infections is RareSarah E Waldman, M.D, Tara Buehring, M.P.H, Daniel J Escobar, M.D, Shruti K Gohil, M.D., M.P.H, Ralph Gonzales, M.D., M.S.P.H, Susan S Huang, M.D., M.P.H, Keith Olensl..., Clinical Infectious Diseases, 10/25/2021
- Healthcare-associated infections: where we came from and where we are headedDaniel Escobar; David Pegues, BMJ Quality & Safety, 1/8/2021
- Join now to see all
Professional Memberships
- Member
- Society of Healthcare Epidemiology of AmericaMember
- Infectious Diseases Society of AmericaMember
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: